Table 5.
Sensitivity analysis for the association of second trimester intake of trans fatty acids with risk of preeclampsia and severe preeclampsia. Danish National Birth Cohort, 1998 – 2003. (n = 67,186 pregnancies) 1.
| Cases | Industrial trans fats | Ruminant trans fats | |
|---|---|---|---|
| RR (95% CI) per 1 g/day | RR (95% CI) per 1g/day | ||
| Preeclampsia | |||
| All cases | 1,804 | 1.05 (0.91 – 1.21) | 0.95 (0.87 – 1.03) |
| Diagnosis 2 or more weeks after FFQ | 1,203 | 0.98 (0.82 – 1.18) | 1.00 (0.90 – 1.11) |
| Diagnosis 4 or more weeks after FFQ | 1,157 | 0.96 (0.80 – 1.15) | 0.98 (0.88 – 1.08) |
| Diagnosis 6 or more weeks after FFQ | 1,086 | 0.89 (0.73 – 1.08) | 0.95 (0.86 – 1.06) |
| Severe preeclampsia | |||
| All cases | 402 | 1.12 (0.83 – 1.51) | 0.97 (0.81 – 1.16) |
| Diagnosis 2 or more weeks after FFQ | 270 | 0.98 (0.66 – 1.45) | 1.00 (0.80 – 1.23) |
| Diagnosis 4 or more weeks after FFQ | 248 | 1.02 (0.68 – 1.53) | 0.99 (0.79 – 1.24) |
| Diagnosis 6 or more weeks after FFQ | 212 | 0.84 (0.53 – 1.34) | 0.92 (0.72 – 1.18) |
1
All models are adjusted for age, total energy intake, pre-pregnancy BMI, height, parity, smoking status, education and year of pregnancy.